Publication | Closed Access

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

ThrombosisCardiovascular DiseasePharmacologyCardiovascular PharmacologyPharmacotherapyAtrial FibrillationPublic HealthMedicineAnticoagulantCardiologyEdoxaban Versus Enoxaparin–warfarin